Ironwood Pharmaceuticals (IRWD) Intangibles (2016 - 2026)

Ironwood Pharmaceuticals has disclosed Intangibles across 7 years of filings, most recently posting $1.8 million for Q1 2026.

• Intangibles for Q1 2026 came in at $1.8 million, down 30.85% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.8 million (down 30.85% YoY), and the FY2025 annual result was $2.0 million, down 28.67% from the prior year.
• Intangibles came in at $1.8 million for Q1 2026 at Ironwood Pharmaceuticals, down from $2.0 million in the prior quarter.
• In the past five years, Intangibles ranged from a high of $4.1 million in Q2 2023 to a low of $1.8 million in Q1 2026.
• The 4-year median for Intangibles is $3.0 million (2024), against an average of $3.0 million.
• Across the five-year window, Intangibles dropped 20.09% in 2024 and plunged 30.85% in 2026, its largest moves.
• Ironwood Pharmaceuticals' Intangibles stood at $3.7 million in 2023, then slipped by 22.32% to $2.9 million in 2024, then decreased by 28.67% to $2.0 million in 2025, then decreased by 9.9% to $1.8 million in 2026.
• The last three Intangibles figures came in at $1.8 million (Q1 2026), $2.0 million (Q4 2025), and $2.2 million (Q3 2025), per Business Quant data.